# NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical Practice

> **NCT07036718** · — · TERMINATED · sponsor: **Novartis Pharmaceuticals** · enrollment: 6 (actual)

## Conditions studied

- Paroxysmal Nocturnal Hemoglobinuria

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07036718
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2025-07-29
- **Primary completion:** 2025-12-25
- **Final completion:** 2025-12-25
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07036718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07036718, "NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical Practice". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07036718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*